Nodexus Inc. news

Nodexus was selected for an SBIR grant for the development of a novel cancer stem cell detection and isolation platform leveraging the core Nodexus technology suite.

Nodexus was selected as an invited exhibitor at the American Diabetes Association HealthTech Showcase in November 2020.

Nodexus was awarded a NOSI grant for the development of an urgently needed COVID-19 diagnostic platform leveraging the core Nodexus technology suite.

Our entire team’s thoughts are with the families of everyone who has been affected by the COVID-19 pandemic.  We salute the effort of healthcare professionals, public/private institutions, and governments the world over to hopefully bring a speedy resolution to these unprecedented times.